Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Racial differences in lung cancer.

Shirish M Gadgeel1, Gregory P Kalemkerian

  • 1Department of Medicine, Wayne State University, Karmanos Cancer Institute, Detroit, MI, USA.

Cancer Metastasis Reviews
|April 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population.

JCO global oncology·2026
Same author

Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced <i>ALK</i>-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.

JCO precision oncology·2026
Same author

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions.

JCO precision oncology·2025
Same author

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).

Clinical lung cancer·2025
Same journal

Metastasis as a breakdown of the multicellular social contract.

Cancer metastasis reviews·2026
Same journal

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

Cancer metastasis reviews·2026
Same journal

Resolving translational challenges in cancer biology through yeast experimental evolution.

Cancer metastasis reviews·2026
Same journal

Spheroids and organoids to study long noncoding RNAs in cancer: how they could replace animal models.

Cancer metastasis reviews·2026
Same journal

Strategies and successes of smoking cessation methods in head and neck cancer patients: a systematic review.

Cancer metastasis reviews·2026
Same journal

The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.

Cancer metastasis reviews·2026
See all related articles

Blacks have higher lung cancer incidence and poorer survival rates compared to whites, particularly in younger men. Further research is needed to understand and address these disparities in lung cancer.

Area of Science:

  • Oncology
  • Public Health
  • Epidemiology

Background:

  • Racial disparities in cancer are well-documented, with lung cancer showing significant differences.
  • Lung cancer incidence rates are consistently higher in Black populations compared to White populations.
  • These disparities are more pronounced in men and younger age groups.

Purpose of the Study:

  • To investigate racial differences in lung cancer incidence, characteristics, and survival.
  • To explore potential factors contributing to observed racial disparities in lung cancer.
  • To highlight the need for targeted interventions to address lung cancer inequities.

Main Methods:

  • Retrospective analysis of lung cancer incidence and survival data stratified by race.
  • Examination of disease characteristics, including histology and stage at diagnosis, across racial groups.

Related Experiment Videos

  • Review of potential contributing factors such as smoking, socioeconomic status, and carcinogen metabolism.

    • Main Results:

    • Black individuals exhibit higher lung cancer incidence rates than White individuals, especially in younger males.
    • Black patients are more likely to be diagnosed with squamous cell carcinoma and advanced-stage lung cancer.
    • A significant survival gap exists, with Black patients experiencing poorer prognoses, particularly for localized and regional disease.

    Conclusions:

    • Significant racial disparities persist in lung cancer incidence and survival.
    • The underlying biological and societal factors driving these differences remain to be elucidated.
    • Further research is crucial for developing effective interventions to reduce lung cancer disparities.